Key Segments:
By Mesh Type
-
Synthetic
-
Biologic
-
Composite
By Mesh Material
-
Non-Absorbable
-
Partially Absorbable
-
Fully Absorbable
By Hernia Type
-
Inguinal
-
Ventral
-
Incisional
-
Femoral
-
Umbilical
-
Others
By Surgical Technique
-
Open
-
Laparoscopic
-
Robotic
By End-User
-
Hospitals
-
Ambulatory Surgical Centers
-
Specialty Clinics
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Poland
-
Russia
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Key players include Medtronic plc, Ethicon, Inc., W. L. Gore & Associates, Inc., Becton, Dickinson and Company, B. Braun Melsungen AG, and Cook Medical LLC, among other medical device manufacturers.
Development of resorbable and reinforced biologic meshes and the shift of hernia surgery into ambulatory surgical centers represent the primary opportunities.
Growth is primarily driven by rising hernia prevalence linked to ageing and obesity, together with wider adoption of minimally invasive and robotic surgery.
By Mesh Type, Synthetic mesh dominated the market with an 83.70% share in 2025, reflecting its strength, low cost, and long clinical track record.
North America dominated the market with a 36.20% share in 2025, supported by high surgical volumes and broad insurance coverage.
